Long Acting Reversible Contraceptive Methods (LARC)

Today we review the classic topic of LARCs! We’ll spend our focus on the specifics of each method. However, in general LARCs are recommended by ACOG as the most effective form of reversible contraception. This is in large part due to their effectiveness independent of coitus and user motivation/adherence to the method. They also enjoy the highest continuation rate and user satisfaction of any method, along with their quality of being reversible with rapid return to fertility. There are also few contraindications to these methods — so what’s not to love?

We’ve put together a comparison table for your studying.

(c) CREOGS over Coffee, 2019

Vulvovaginal Itching

Today we’re working up the classic GYN sick visit in vulvovaginal itching. We recommend The V Book by Elizabeth Stewart, MD, and though we haven’t read Dr. Jen Gunter’s The Vagina Bible yet, we’ve heard great things!

We start off the episode with a review of things that can cause itching, stratifying from benign to more worrisome. For benign causes, the primary culprit is vaginitis. Think yeast (Candida), bacterial vaginosis, or less commonly gonorrhea/chlamydia or trichomoniasis. Another benign cause is desquamative inflammatory vaginitis, that can be associated with large amounts of discharge. Genitourinary syndrome of menopause, or atrophic vagnitis, is another common cause in postmenopausal women.

Benign dermatoses of the vulva can include lichen planus, which manifests as a red or purplish raised rash, that can present as hypertrophic or ulcerative. It can further lead to lichen simplex chronicus, which is an area of thickened skin due to repeated excoriation. Lichen planus can also involve other areas of the body. Finally, benign dermatoses like eczema, contact dermatitis, or psoriasis can also affect the vulva.

More worrisome dermatoses can include lichen sclerosus. Generally benign, this is a chronic, progressive inflammatory mucocutaneous disease that peaks in prepubertal and in menopausal women. The skin becomes thin and parchment-paper or “cigarette paper”-like in consistency, whitening, and destruction of the architecture and narrowing of the vaginal introits. It can be worrisome, particularly in older women, because it can harbor vulvar intraepithelial neoplasia (VIN) or squamous vulvar cancer. Of course, both of those can also occur on their own, often in the context of HPV infection.

Another malignant dermatosis is extramammary Paget’s disease. In this case, the vulva have an eczematous appearance with slightly raised edges and a red background. This is rare, with the malignancy originating in the vulvar apocrine-gland-bearing skin cells.

Ok, so lots of things can cause this itching, but what should we do? Always start with a complete history and physical. Histories should have special focus on vulvar hygiene, as this is often the culprit. A physical exam should include all skin including the vulva, to rule out more significant dermatoses. With the vulva, we advise a “top down” systematic approach before proceeding with the speculum exam.

The gynecologists handy tool will be the wet mount. Vaginal pH should be < 4.5, and basic pHs may suggest infection or poor lactobacillus presence. Dropping 20% KOH solution on the slide will allow for better visualization of yeast, as well as allow for the performance of the whiff test. On microscopy, you should see plenty of squamous cells (large, squarish cells with small nucleus or no nucleus), compared to paranasal cells (small round cells with prominent nuclei). Sheets of squamous cells with paranasal cells suggests desquamative inflammatory vaginitis. Clue cells have stippled or fuzzy borders along squamous cells. Yeast often has the classic ‘budding pseudohyphae’ or ‘spaghetti and meatballs’ appearance.

Genital cultures may be helpful in identifying resistant or unusual organisms, such as Candida glabratta. If allergies are suspected, referral for patch testing may be worthwhile if avoidance isn’t feasible. Biopsy should be performed to rule out malignancy at ulcerating areas, with lichen sclerosus, or with other areas of concern.

With vulvar hygiene, go as simple as possible. As our mentor Dr. Crichton always says: if you wouldn’t put it in your eye, don’t put it on the vulva. Recommend cotton underwear during the day, no underwear at night; unscented detergents and soaps; only water on vulva; latex condoms and provide own lube with silicone lube; avoid panty liners every day, only during periods . Coconut oil makes for excellent personal moisturizer and lubricant.

If something is present, you should treat the condition. Infections should be treated with appropriate antimicrobials. Lichen planus should be given symptomatic treatment to stop itching. Lichen sclerosus often will need high potency steroids (i.e., clobetasol) to resolve. Malignancies will require excision with referral to oncology for true invasive cancers.

Benign Breast Disease

Today’s episode suggestion comes to us from Shadae Beale, a resident at Meharry Medical College. Thanks for listening! And be sure to send us your ideas through the website or via email!

We kicked off today’s episode with a vignette:

24 yo F G1P1 with 10 year history of type 1 diabetes presents with right breast mass that she palpated in the shower. She is currently breastfeeding her 9 mo old baby. She states that she has had some pain in her right breast, though no redness or swelling, and that she has always had “lumpy breasts.” She is worried because her 78 yo grandmother was recently diagnosed with breast cancer. No other breast or ovarian cancer in her family. On exam, she has lumpy, cobblestone texture of both breasts, with free-moving tissue throughout. There is one 2x2cm firm, mildly tender, mobile mass in the R breast at the 2 o’clock position, approximately 1 cm from the nipple. No axillary lymphadenopathy. 

Now we imagine that if this isn’t a likely scenario in your clinic time, it is on your test prep questions. What do you do with this patient? Let’s first review a broad differential diagnosis for a likely benign mass:

Nonproliferative Breast Lesions 

  • Breast cysts 

    • Simple cysts - benign, fluid filled mass; usually discrete, compressible, or ballotable solitary mass 

    • Galactocele - milk retention cyst common in women who are breastfeeding 

  • Fibrocystic changes - common, especially in premenopausal women; may cause breast pain 

  • Lipoma - mature fat cells 

  • Fat necrosis - can develop after blunt trauma to the breast; can also occur after surgery (ie. breast reconstruction, radiation therapy); associated generally with skin ecchymosis 

  • Breast abscess - localized collection of inflammatory exudate; can develop alongside mastitis or cellulitis; usually will have all the signs of infection! 

  • Diabetic mastopathy 

    • Usually in women with longstanding T1DM 

    • Suspicious fibrous breast lumps, usually multiple 

    • Need to biopsy for diagnosis

  • Idiopathic granulomatous mastitis 

    • Rare inflammatory disease of the breast - usually presents as a painful, firm and ill-defined mass that can have erythema and edema of the skin 

Proliferative Breast Lesions without Atypia 

  • Intraductal papillomas 

    • Monotonous array of papillary cells that grow from the wall of a cyst into its lumen.

    • Most common cause of bloody nipple discharge (key to any vignette!)

    • Generally not concerning, but CAN harbor DCIS; can be solitary or multiple lesions. If bothersome or concern for atypia, surgical excision is performed.

Intraductal papilloma. (C) WebPathology.

  • Sclerosing adenosis - lobular lesion with increased fibrous tissue; no need to treat.

  • Radial scar - complex sclerosing lesions; usually diagnosed after biopsy. Recommend excision, but no other treatment .

  • Fibroadenoma 

    • Most common benign tumor in the breast, accounting for ½ of all breast biopsies 

    • Glandular and fibrous tissue, presenting as a well defined, mobile mass on exam.

Atypical Hyperplasia 

  • Atypical ductal hyperplasia (ADH)

    • Proliferation of uniform epithelial cells with round nuclei fill part of the duct.

    • Standard of care after biopsy-proven diagnosis is surgical excision, due to risk of upgrade to ductal carcinoma.

  • Atypical lobular hyperplasia (ALH)

    • Monomorphic, evenly spaced dyshesive cells fill part of the lobule; can also involve ducts.

    • Referral to breast onc should occur, as management varies based on other clinical risk factors.

OK, so now you have a differential — what do we still need to do for this patient in front of us?

Always starting off with a history is important. With respect the HPI, it’s important to know not only about the characteristic of the mass, but any changes to the mass and the timiing of changes. For instance, is it painful, but cyclically painful with menses? That would argue more for fibrocystic changes. Has it grown in size over the last 3 months and caused nipple inversion in the meantime? That’s more worrisome for malignancy.

Family history and social history are also exceptionally important. Smoking increases risks of certain breast pathologies. And family history is obviously tantamount to determining a patient’s risk for particularly early-onset breast cancer.

Physical examination should include both breasts, examined in both a sitting and recumbent position. Note asymmetry, skin changes, nipple changes, and the location of masses. Generally using clock face language is most helpful for your referral: i.e., “12:00 position, 3cm from nipple” is highly descriptive. Finally, a regional lymph node exam should also be performed. Generally this includes axillary and supraclavicular nodes.

Imaging is what we will turn to next. For the younger patient, targeted breast ultrasound is an excellent choice, as it’s more sensitive than mammogram in this population with denser breast tissue. It also allows for immediate biopsy should the reading radiologist decide it’s indicated. Diagnostic mammography is also a standard of care in anyone with a palpable breast mass who meets criteria for screening. Definitive diagnosis is achieved with biopsy — core biopsy for solid lesions, fine needle aspiration for cysts, or excisional tissue biopsy as another option.

Abnormal Uterine Bleeding: The Basics

Today we talk through the varied etiologies and a basic workup for a common GYN complaint: abnormal uterine bleeding. ACOG PB 128 makes for good companion reading for women of reproductive age.

The terminology of AUB has changed quite a bit, and you may still hear older terms being used. “Dysfunctional uterine bleeding” or DUB has fallen out of favor, as have terms such as metrorrhagia or menorrhagia, yielding instead to simpler terminology such as prolonged menstrual bleeding and heavy menstrual bleeding, respectively. The terms such as oligomenorrhea (bleeding cycles > 35 days apart) and polymenorrhea (cycles < 21 days apart) are also in use to some degree.

Heavy bleeding is difficult to discern, but for research purposes has been described as >80cc blood loss per cycle. In clinical practice, this is obviously impractical, so we rely on subjective descriptions of heavy bleeding to guide care.

The biggest takeaways from this episode include the PALM-COIEN classification of bleeding by FIGO, as well as the common culprits of bleeding by age group. Remember also the criteria for working up for disorders of coagulation, which we’ve put here (though contained in the practice bulletin).

Stay tuned for future episodes about the treatments of these various etiologies, or check out our friends at The OBG Project for excellent summaries of guidelines and new literature!

ACOG PB 128

ACOG PB 128

ACOG PB 128

Care of the Transgender Patient

Today we sit down with Dr. Beth Cronin, clinical associate professor and assistant program director at Brown / Women and Infants of Rhode Island. Dr. Cronin has become a national expert in the care of LGBTQ patients, and is a fixture at ACOG and other venues, and we are lucky enough today to have her break down the need-to-know essentials for the OB/Gyn.

Definitions are an excellent place to start, and set the stage for this conversation:

  • Sex is what we do in the delivery room - defining “male” or “female” based on the presence of external genitalia.

  • Gender is a social construct, comprising attitudes, feelings, or behaviors associated to “male” or “female” by a culture.

  • Gender identity is a person’s internal sense of their gender:

    • Cisgender the biological sex and gender identity align

    • Transgender the biological sex and gender identity are opposite:

      • Transgender woman biological sex male, identity female

      • Transgender man biological sex female, identify male

    • Gender should be viewed along a spectrum, with varying definitions for terms such as gender fluid, gender queer, or nonbinary.

About 1.4 million adults and 150,000 youth aged 13-17 are estimated to identify as transgender or gender non-binary in the United States. This population has much higher risks of experiencing discrimination, violence, and sexual assault. Additionally, these patients are likely to have poor experiences in healthcare settings. These patients really need access to care, and OB/Gyns are in perfect position to be safe and welcoming environments for the transgender/gender non-binary community.

For your office and daily practice, it is important to be inclusive, and there are myriad resources to get this started. Staff training and education to promote inclusivity is also important. Inclusive forms and medical record systems that elicit gender identity are important to make available, including documentation of preferred pronouns.

Dr. Cronin also took time today to discuss some clinical care aspects. UCSF and WPATH each have excellent protocols and guidelines for clinical care, including for initiating or maintaining transition care. Modifications of usual care, and care in the midst of hormonal transition, is discussed in great detail at these resources. ACOG also has excellent online modules for OB/Gyns for transgender healthcare, in addition to more primary reading at CO 512, CO 685, and additional ACOG-approved resources for clinicians.

Dr. Cronin easily explains it as “screen the parts that are present” per usual care guidelines, including with respect to things such as breast and cervical cancer screening, contraceptive methods, and pregnancy and abortion care.